Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Rapid eye movement sleep mediates age-related decline in prospective memory consolidation.

Scullin MK, Gao C, Fillmore P, Roberts RL, Pruett N, Bliwise DL.

Sleep. 2019 Jun 11;42(6). pii: zsz055. doi: 10.1093/sleep/zsz055.

PMID:
30860593
2.

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Stamp LK, Wallace M, Roberts RL, Frampton C, Miner JN, Merriman TR, Dalbeth N.

Drug Metab Pharmacokinet. 2018 Dec;33(6):241-242. doi: 10.1016/j.dmpk.2018.09.002. Epub 2018 Sep 18. No abstract available.

PMID:
30274827
3.

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.

Roberts RL, Wallace MC, Harrison AA, White D, Dalbeth N, Stamp LK, Ching D, Highton J, Merriman TR, Robinson PC, Brown MA, Stebbings SM.

PeerJ. 2018 Jun 26;6:e5088. doi: 10.7717/peerj.5088. eCollection 2018.

4.

Urethral Steinstrasse following Laser Lithotripsy of Prostatic Urethral Calculi.

Den J, Kerr PS, Dafashy TJ, Kosarek CD, Roberts RL, Sreshta JN.

Case Rep Urol. 2018 May 9;2018:3459347. doi: 10.1155/2018/3459347. eCollection 2018.

5.

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Roberts RL, Wallace MC, Seinen ML, van Bodegraven AA, Krishnaprasad K, Jones GT, van Rij AM, Baird A, Lawrance IC, Prosser R, Bampton P, Grafton R, Simms LA, Studd C, Bell SJ, Kennedy MA, Halliwell J, Gearry RB, Radford-Smith G, Andrews JM, McHugh PC, Barclay ML.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2606-2612. doi: 10.1093/ibd/izy163.

PMID:
29788244
6.

Mindful Self-Hypnosis for Self-Care: An Integrative Model and Illustrative Case Example.

Elkins GR, Roberts RL, Simicich L.

Am J Clin Hypn. 2018 Jul;61(1):45-56. doi: 10.1080/00029157.2018.1456896.

PMID:
29771220
7.

Brief Report: Knowledge of, Interest in, and Willingness to Try Behavioral Interventions in Individuals With Parkinson's Disease.

Benge JF, Roberts RL, Kekecs Z, Elkins G.

Adv Mind Body Med. 2018 Winter;32(1):8-12.

PMID:
29406302
8.

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.

Wallace MC, Roberts RL, Nanavati P, Miner JN, Dalbeth N, Topless R, Merriman TR, Stamp LK.

Rheumatology (Oxford). 2018 Apr 1;57(4):656-660. doi: 10.1093/rheumatology/kex467. Review.

PMID:
29342288
9.

A peripelvic renal cyst resulting in clinically symptomatic ureteropelvic junction obstruction.

Coggins WS, Hudgins HK, Kosarek CD, Roberts RL.

Urol Case Rep. 2017 Nov 21;16:69-71. doi: 10.1016/j.eucr.2017.11.001. eCollection 2018 Jan. No abstract available.

10.

Hypnosis for Hot Flashes and Associated Symptomsin Women with Breast Cancer.

Roberts RL, Na H, Yek MH, Elkins G.

Am J Clin Hypn. 2017 Oct;60(2):123-136. doi: 10.1080/00029157.2017.1334622. Review.

PMID:
28891773
11.

Feasibility of Music and Hypnotic Suggestion to Manage Chronic Pain.

Johnson AJ, Kekecs Z, Roberts RL, Gavin R, Brown K, Elkins GR.

Int J Clin Exp Hypn. 2017 Oct-Dec;65(4):452-465. doi: 10.1080/00207144.2017.1348858.

PMID:
28836920
12.

Chronic methamphetamine exposure significantly decreases microglia activation in the arcuate nucleus.

Lloyd SA, Corkill B, Bruster MC, Roberts RL, Shanks RA.

J Chem Neuroanat. 2017 Jul;82:5-11. doi: 10.1016/j.jchemneu.2017.03.001. Epub 2017 Mar 18.

PMID:
28323108
13.

Optimizing Sperm Collection Procedures in Zebrafish.

Wasden MB, Roberts RL, DeLaurier A.

J S C Acad Sci. 2017;15(2). pii: 7.

14.

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

Saffian SM, Duffull SB, Roberts RL, Tait RC, Black L, Lund KA, Thomson AH, Wright DF.

Ther Drug Monit. 2016 Dec;38(6):677-683.

15.

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.

Roberts RL, Wallace MC, Phipps-Green AJ, Topless R, Drake JM, Tan P, Dalbeth N, Merriman TR, Stamp LK.

Pharmacogenomics J. 2017 Mar;17(2):201-203. doi: 10.1038/tpj.2015.101. Epub 2016 Jan 26.

PMID:
26810134
16.

Update on thiopurine pharmacogenetics in inflammatory bowel disease.

Roberts RL, Barclay ML.

Pharmacogenomics. 2015 Jul;16(8):891-903. doi: 10.2217/pgs.15.29. Epub 2015 Jun 12. Review.

PMID:
26067482
17.

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout.

Roberts RL, Wallace MC, Harrison A, Dalbeth N, Merriman TR, Stamp LK.

Pharmacogenet Genomics. 2015 Aug;25(8):412-5. doi: 10.1097/FPC.0000000000000147.

PMID:
26049586
18.

Pharmacogenetic considerations in the treatment of gout.

Roberts RL, Stamp LK.

Pharmacogenomics. 2015;16(6):619-29. doi: 10.2217/pgs.15.16. Epub 2015 Apr 16. Review.

PMID:
25876828
19.

Successful stem cell transplantation in Chediak-Higashi syndrome.

Thakor A, Geng B, Liebhaber M, Moore T, Wang K, Roberts RL.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):271-2. doi: 10.1016/j.jaip.2014.09.005. Epub 2014 Nov 18. No abstract available.

PMID:
25609327
20.

Methods for Predicting Warfarin Dose Requirements.

Saffian SM, Wright DF, Roberts RL, Duffull SB.

Ther Drug Monit. 2015 Aug;37(4):531-8. doi: 10.1097/FTD.0000000000000177.

PMID:
25549208
21.

Phosphoinositide-3 kinase inhibition modulates responses to rhinovirus by mechanisms that are predominantly independent of autophagy.

Ismail S, Stokes CA, Prestwich EC, Roberts RL, Juss JK, Sabroe I, Parker LC.

PLoS One. 2014 Dec 26;9(12):e116055. doi: 10.1371/journal.pone.0116055. eCollection 2014.

22.

Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease.

Doecke JD, Simms LA, Zhao ZZ, Roberts RL, Fowler EV, Croft A, Lin A, Huang N, Whiteman DC, Florin TH, Barclay ML, Merriman TR, Gearry RB, Montgomery GW, Radford-Smith GL.

J Gastroenterol Hepatol. 2015 Feb;30(2):299-307. doi: 10.1111/jgh.12674.

PMID:
24989722
23.

Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.

Stamp LK, Merriman TR, Barclay ML, Singh JA, Roberts RL, Wright DF, Dalbeth N.

Semin Arthritis Rheum. 2014 Oct;44(2):170-4. doi: 10.1016/j.semarthrit.2014.05.007. Epub 2014 May 9. Review.

24.

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Roberts RL, Wallace MC, Seinen ML, Krishnaprasad K, Chew A, Lawrance I, Prosser R, Bampton P, Grafton R, Simms L, Studd C, Bell SJ, Radford-Smith G, Andrews JM, Barclay ML.

Am J Gastroenterol. 2014 Jun;109(6):925-7. doi: 10.1038/ajg.2014.89. No abstract available. Erratum in: Am J Gastroenterol. 2015 Jan;110(1):204. Studd, Corrie [added]; Bell, Sally J [added].

PMID:
24896764
25.

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.

Chin PK, Wright DF, Zhang M, Wallace MC, Roberts RL, Patterson DM, Jensen BP, Barclay ML, Begg EJ.

Drugs R D. 2014 Jun;14(2):113-23. doi: 10.1007/s40268-014-0045-9.

26.

Identification of a novel thiopurine S-methyltransferase allele (TPMT*37).

Roberts RL, Wallace MC, Drake JM, Stamp LK.

Pharmacogenet Genomics. 2014 Jun;24(6):320-3. doi: 10.1097/FPC.0000000000000049.

PMID:
24710034
27.

Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity.

Roberts RL, Wallace MC, Jones GT, van Rij AM, Merriman TR, Harrison A, White D, Stamp LK, Ching D, Highton J, Stebbings SM.

Arthritis Res Ther. 2013 Oct 22;15(5):R158. doi: 10.1186/ar4341.

28.

Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL.

World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656. Review.

29.

Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians.

Ngu JH, Wallace MC, Merriman TR, Gearry RB, Stedman CA, Roberts RL.

Springerplus. 2013 Jul 30;2:355. doi: 10.1186/2193-1801-2-355. eCollection 2013.

30.

Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone.

Roberts RL, Wallace MC, Wright DF, Cadzow M, Dalbeth N, Jones PB, Stamp LK, Harrison AA, Black MA, Merriman TR.

Joint Bone Spine. 2014 Mar;81(2):160-3. doi: 10.1016/j.jbspin.2013.07.006. Epub 2013 Aug 7.

PMID:
23932726
31.

Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.

Doecke JD, Simms LA, Zhao ZZ, Huang N, Hanigan K, Krishnaprasad K, Roberts RL, Andrews JM, Mahy G, Bampton P, Lewindon P, Florin T, Lawrance IC, Gearry RB, Montgomery GW, Radford-Smith GL.

Inflamm Bowel Dis. 2013 Feb;19(2):240-5. doi: 10.1097/MIB.0b013e3182810041.

PMID:
23348120
32.

Msh2-Msh3 interferes with Okazaki fragment processing to promote trinucleotide repeat expansions.

Kantartzis A, Williams GM, Balakrishnan L, Roberts RL, Surtees JA, Bambara RA.

Cell Rep. 2012 Aug 30;2(2):216-22. doi: 10.1016/j.celrep.2012.06.020. Epub 2012 Aug 2.

33.

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

Roberts RL, Barclay ML.

J Gastroenterol Hepatol. 2012 Oct;27(10):1546-54. doi: 10.1111/j.1440-1746.2012.07220.x. Review.

PMID:
22741564
34.

Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study.

Bentley RW, Keown DA, Gearry RB, Cameron VA, Keenan J, Roberts RL, Day AS.

N Z Med J. 2012 Jun 8;125(1356):47-51.

PMID:
22729058
35.

Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action.

Stamp LK, Hazlett J, Roberts RL, Frampton C, Highton J, Hessian PA.

Arthritis Res Ther. 2012 Jun 8;14(3):R138. doi: 10.1186/ar3871.

36.

Cord blood transplants for SCID: better B-cell engraftment?

Chan WY, Roberts RL, Moore TB, Stiehm ER.

J Pediatr Hematol Oncol. 2013 Jan;35(1):e14-8. doi: 10.1097/MPH.0b013e31824e15b8.

PMID:
22510776
37.

Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin.

Jensen BP, Chin PK, Roberts RL, Begg EJ.

Br J Clin Pharmacol. 2012 Nov;74(5):797-805. doi: 10.1111/j.1365-2125.2012.04259.x.

38.

The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patients.

Vella-Brincat JW, Begg EJ, Jensen BP, Chin PK, Roberts RL, Fairhall M, Macleod SA, Reid K.

J Pain Symptom Manage. 2012 Mar;43(3):540-8. doi: 10.1016/j.jpainsymman.2011.04.022. Epub 2011 Dec 30.

PMID:
22209223
39.

Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.

Stamp LK, Roberts RL.

Pharmacogenomics. 2011 Oct;12(10):1449-63. doi: 10.2217/pgs.11.86. Review.

PMID:
22008049
40.

Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers.

Jensen BP, Roberts RL, Vyas R, Bonke G, Jardine DL, Begg EJ.

Br J Clin Pharmacol. 2012 Apr;73(4):619-28. doi: 10.1111/j.1365-2125.2011.04126.x.

41.

Simultaneous bridge-localized and mixed-valence character in diruthenium radical cations featuring diethynylaromatic bridging ligands.

Fox MA, Le Guennic B, Roberts RL, Brue DA, Yufit DS, Howard JA, Manca G, Halet JF, Hartl F, Low PJ.

J Am Chem Soc. 2011 Nov 16;133(45):18433-46. doi: 10.1021/ja207827m. Epub 2011 Oct 24.

PMID:
21958078
42.

NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease.

Glubb DM, Gearry RB, Barclay ML, Roberts RL, Pearson J, Keenan JI, McKenzie J, Bentley RW.

World J Gastroenterol. 2011 Jun 21;17(23):2829-37. doi: 10.3748/wjg.v17.i23.2829.

43.

Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms.

Roberts RL, Van Rij AM, Phillips LV, Young S, McCormick SP, Merriman TR, Jones GT.

Atherosclerosis. 2011 Sep;218(1):123-6. doi: 10.1016/j.atherosclerosis.2011.04.043. Epub 2011 May 10.

PMID:
21621776
44.

Independent replication of an association of CNVR7113.6 with Crohn's disease in Caucasians.

Roberts RL, Diaz-Gallo LM, Barclay ML, Gómez-García M, Cardeña C, Merriman TR, Gearry RB, Martin J.

Inflamm Bowel Dis. 2012 Feb;18(2):305-11. doi: 10.1002/ibd.21752. Epub 2011 May 10.

PMID:
21560206
45.

Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males.

Bentley RW, Keown D, Merriman TR, Raj Krishnan M, Gearry RB, Barclay ML, Roberts RL, Day AS.

Aliment Pharmacol Ther. 2011 Apr;33(7):855-6. doi: 10.1111/j.1365-2036.2011.04588.x. No abstract available.

46.

Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis.

Diaz-Gallo LM, Espino-Paisán L, Fransen K, Gómez-García M, van Sommeren S, Cardeña C, Rodrigo L, Mendoza JL, Taxonera C, Nieto A, Alcain G, Cueto I, López-Nevot MA, Bottini N, Barclay ML, Crusius JB, van Bodegraven AA, Wijmenga C, Ponsioen CY, Gearry RB, Roberts RL, Weersma RK, Urcelay E, Merriman TR, Alizadeh BZ, Martin J.

Inflamm Bowel Dis. 2011 Nov;17(11):2287-94. doi: 10.1002/ibd.21630. Epub 2011 Feb 1.

47.

Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease.

Roberts RL, Hollis-Moffatt JE, Gómez-García M, Fransen K, Ponsioen CY, Crusius BA, Wijmenga C, Martín J, Weersma RK, Merriman TR, Barclay ML, Gearry RB, Alizadeh BZ.

Inflamm Bowel Dis. 2011 Feb;17(2):E19-21. doi: 10.1002/ibd.21470. Epub 2010 Dec 13. No abstract available.

PMID:
21225905
48.

SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status.

Stewart LC, Day AS, Pearson J, Barclay ML, Gearry RB, Roberts RL, Bentley RW.

World J Gastroenterol. 2010 Dec 7;16(45):5727-31.

49.

Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?

Roberts RL, Gearry RB, Barclay ML.

Pharmacogenomics. 2010 Nov;11(11):1505-8. doi: 10.2217/pgs.10.143. No abstract available.

50.

Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases.

Moy JN, Scharenberg AM, Stein MR, Suez D, Roberts RL, Levy RJ, Ballow M, Fasano MB, Dash CH, Leach SJ.

Clin Exp Immunol. 2010 Dec;162(3):510-5. doi: 10.1111/j.1365-2249.2010.04247.x.

Supplemental Content

Loading ...
Support Center